Q2 2024 Holdings
Filed 2024-08-14 | 51 holdings | $437.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Harrow Health Inc(HROW) | COM | 415858109 | $83.4M | 3,990,000 | 19.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $40.6M | 2,280,000 | 9.3% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $36.3M | 5,307,500 | 8.3% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $21.1M | 515,000 | 4.8% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $16.8M | 367,500 | 3.8% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $14.8M | 555,000 | 3.4% |
| Immunome Inc(IMNM) | COM | 45257U108 | $13.3M | 1,102,500 | 3.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $10.8M | 198,500 | 2.5% |
| Codexis Inc(CDXS) | COM | 192005106 | $10.7M | 3,455,000 | 2.4% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $10.4M | 580,000 | 2.4% |
| Catalyst Pharmaceuticals Inc(CPRX) | COM | 14888U101 | $9.9M | 640,000 | 2.3% |
| Cargo Therapeutics Inc(CRGX) | COM | 14179K101 | $9.1M | 555,700 | 2.1% |
| Jasper Therapeutics Inc(JSPR) | COM NEW | 471871202 | $8.9M | 392,000 | 2.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $8.7M | 418,928 | 2.0% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $7.9M | 2,645,000 | 1.8% |
| Eton Pharmaceuticals Inc(ETON) | COM | 29772L108 | $7.9M | 2,395,000 | 1.8% |
| Applied Therapeutics Inc'(APLT) | COM | 03828A101 | $7.8M | 1,680,000 | 1.8% |
| 4D Molecular Therapeutics Inc(FDMT) | COM | 35104E100 | $7.3M | 345,750 | 1.7% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $7.2M | 897,000 | 1.6% |
| Acelyrin Inc | COM | 00445A100 | $7.0M | 1,580,000 | 1.6% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $6.9M | 412,000 | 1.6% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $6.4M | 85,000 | 1.5% |
| Biodesix Inc | COM | 09075X108 | $6.2M | 4,020,000 | 1.4% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $6.1M | 315,000 | 1.4% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $5.9M | 250,000 | 1.4% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $5.3M | 2,304,262 | 1.2% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $4.9M | 218,000 | 1.1% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $4.5M | 59,300 | 1.0% |
| Syros Pharmaceuticals Inc(SYRS) | COM NEW | 87184Q206 | $4.5M | 865,443 | 1.0% |
| Gossamer BIO Inc | NOTE 5.000% 6/0 | 38341PAA0 | $4.0M | $8,000,000 | 0.9% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $3.9M | 325,000 | 0.9% |
| Karyopharm Therapeutics Inc | NOTE 3.000%10/1 | 48576UAA4 | $3.7M | $6,000,000 | 0.9% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $3.6M | 105,000 | 0.8% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $3.5M | 3,910,000 | 0.8% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $3.2M | 1,875,000 | 0.7% |
| Savara Inc(SVRA) | COM | 805111101 | $2.9M | 714,960 | 0.7% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $2.8M | 2,780,000 | 0.6% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $2.7M | 1,190,000 | 0.6% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $2.7M | 915,000 | 0.6% |
| Regulus Therapeutics Inc(RGLS) | COM | 75915K309 | $2.6M | 1,475,000 | 0.6% |
| Lyell Immunopharma Inc | COM | 55083R104 | $2.4M | 1,670,000 | 0.6% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $1.8M | 600,000 | 0.4% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $1.8M | 285,000 | 0.4% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $1.2M | 1,425,000 | 0.3% |
| Ibio Inc(IBIO) | COM NEW | 451033708 | $791.3K | 375,000 | 0.2% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $769.5K | 475,000 | 0.2% |
| Aerovate Therapeutics Inc | COM | 008064107 | $730.4K | 440,000 | 0.2% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $686.8K | 205,000 | 0.2% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $592.0K | 200,000 | 0.1% |
| Aligos Therapeutics Inc | COM | 01626L105 | $441.0K | 1,260,000 | 0.1% |